The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
HLA class I antigen abnormalities and immune escape by malignant cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Self-citationImplications for immunosurveillance of altered HLA class I phenotypes in human tumours
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., & Stern, P. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10075-x · Cited by 770
Self-citationIdentification of human cancers deficient in antigen processing.
Restifo, N. P., Esquivel, F., Kawakami, Y., Yewdell, J. W., Mulé, J. J., Rosenberg, S. A., & Bennink, J. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.265 · Cited by 624
Ferrone, S., & Marincola, F. M. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80033-6 · Cited by 474
Self-citationAntigen-processing machinery breakdown and tumor growth
Seliger, B., Maeurer, M. J., & Ferrone, S. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01692-3 · Cited by 459
Self-citationHLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F. A., Avril, M. F., Dausset, J., Guillet, J. G., & Carosella, E. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4510 · Cited by 432
D'Urso, C. M., Wang, Z. G., Cao, Y., Tatake, R., Zeff, R. A., & Ferrone, S. (1991) · Journal of Clinical Investigation · doi:10.1172/jci114984 · Cited by 309
Self-citationKoopman, L. A., Corver, W. E., van der Slik, A. R., Giphart, M. J., & Fleuren, G. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.961 · Cited by 279
The β2-microglobulin gene is on chromosome 15 and not in the HL-A region
GOODFELLOW, P. N., JONES, E. A., VAN HEYNINGEN, V., SOLOMON, E., BOBROW, M., MIGGIANO, V., & BODMER, W. F. (1975) · Nature · doi:10.1038/254267a0 · Cited by 272
c-myc down-regulates class I HLA expression in human melanomas.
Versteeg, R., Noordermeer, I. A., Krüse-Wolters, M., Ruiter, D. J., & Schrier, P. I. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02909.x · Cited by 252
Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer
Sanda, M. G., Restifo, N. P., Walsh, J. C., Kawakami, Y., Nelson, W. G., Pardoll, D. M., & Simons, J. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.4.280 · Cited by 235
Chen, H. L., Gabrilovich, D., Tampé, R., Girgis, K. R., Nadaf, S., & Carbone, D. P. (1996) · Nature Genetics · doi:10.1038/ng0696-210 · Cited by 203
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.
Hicklin, D. J., Wang, Z., Arienti, F., Rivoltini, L., Parmiani, G., & Ferrone, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci498 · Cited by 198
Self-citationIGF-I and IGF-II in relation to colorectal cancer
Manousos, O. N., Souglakos, J., Bosetti, C., Τζώνου, Α., Chatzidakis, V., Trichopoulos, D., Adami, H., & Mantzoros, C. S. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<91::aid-ijc17>3.0.co;2-4 · Cited by 190
Browning, M. J., Krausa, P., Rowan, A., Bicknell, D. C., Bodmer, J. G., & Bodmer, W. F. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2842 · Cited by 167
Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.
Marincola, F. M., Shamamian, P., Alexander, R. B., Gnarra, J. R., Turetskaya, R. L., Nedospasov, S. A., Simonis, T. B., Taubenberger, J. K., Yannelli, J., Mixon, A., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.3.1225 · Cited by 165
Ibrahim, E. C., Guerra, N., Terrier-Lacombe, M.-J., Angevin, E., Chouaïb, S., Carosella, E. D., Caignard, A., & Paul, P. (2001) · PubMed · Cited by 157
Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.
Bicknell, D. C., Rowan, A., & Bodmer, W. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4751 · Cited by 150
Benitez, R., Godelaine, D., López‐Nevot, M. Á., Brasseur, F., Jimenez, P., Marchand, M.-C., Oliva, M. R., van Baren, N., Cabrera, T., Andry, G., et al. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb03082.x · Cited by 149
Self-citationFrancke, U., & Pellegrino, M. A. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.3.1147 · Cited by 146
Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.
Paul, P., Cabestré, F. A., Gal, F. L., Khalil, I., Danff, C. L., Schmid, M., Mercier, S., Avril, M.-F., Dausset, J. B., Guillet, J., et al. (1999) · PubMed · Cited by 144
Multiple mechanisms underlie HLA dysregulation in cervical cancer
Brady, C. S., Bartholomew, J. S., Burt, D. J., Duggan-Keen, M. F., Glenville, S., Telford, N., Little, A., Davidson, J. A., Jiménez, P., Ruiz‐Cabello, F., et al. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550502.x · Cited by 128
Self-citationWagner, S. N., Rebmann, V., Willers, C. P., Grosse‐Wilde, H., & Goos, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02486-7 · Cited by 103
Wang, Z., Marincola, F. M., Rivoltini, L., Parmiani, G., & Ferrone, S. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.205 · Cited by 102
Self-citationMechanisms of loss of HLA class I expression on colorectal tumor cells
Browning, M. J., Petronzelli, F., Bicknell, D. C., Krausa, P., Rowan, A., Tonks, S., Murray, N., Bodmer, J. G., & Bodmer, W. F. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02571.x · Cited by 101
Wang, Z., Cao, Y., Albino, A. P., Zeff, R. A., Houghton, A., & Ferrone, S. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116249 · Cited by 91
Self-citationLoss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line
Torres, M. J., Ruiz‐Cabello, F., Skoudy, A., Berrozpe, G., Jiménez, P., Serrano, A., Real, F. X., & Garrido, F. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02572.x · Cited by 83
Self-citationThe immunotolerance role of HLA-G
Rouas‐Freiss, N., Khalil‐Daher, I., Riteau, B., et al. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0103 · Cited by 82
Delp, K., Momburg, F., Hilmes, C., Huber, C. G., & Seliger, B. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702363 · Cited by 77
Self-citationBlanchet, O., Bourge, J. F., Zinszner, H., Israël, A., Kourilsky, P., Dausset, J. B., Degos, L., & Paul, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3488 · Cited by 66
Structural and functional analysis of β2 microglobulin abnormalities in human lung and breast cancer
Chen, H. L., Gabrilovich, D. I., Virmani, A. K., Ratnani, I., Girgis, K. R., Nadaf, S., Fernández-Viña, M., & Carbone, D. P. (1996) · International Journal of Cancer · Cited by 63
Molecular strategies to define HLA haplotype loss in microdissected tumor cells
Ramal, L. M., Maleno, I., Cabrera, T., Collado, A., Ferrón, A., López‐Nevot, M. Á., & Garrido, F. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00171-3 · Cited by 60
Self-citationImmune surveillance in colorectal carcinoma
Branch, P., Bicknell, D., Rowan, A., Bodmer, W. F., & Karran, P. (1995) · Nature Genetics · doi:10.1038/ng0395-231 · Cited by 60
Locus-specific transcriptional control of HLA genes
Soong, T. W., & Hui, K. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.6.2008 · Cited by 56
Frumento, G., Franchello, S., Palmisano, G. L., Nicotra, M., Giacomini, P., Loke, Y. W., Geraghty, D. E., Maio, M., Manzo, C., Natali, P. G., et al. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.560104.x · Cited by 56
Telomeres, hidden mosaicism, loss of heterozygosity, and complex genetic traits
Aviv, A., & Aviv, H. (1998) · Human Genetics · doi:10.1007/s004390050774 · Cited by 55
Human Leukocyte Antigen Class I Gene Mutations in Cervical Cancer
Koopman, L. A., van der Slik, A. R., Giphart, M. J., & Fleuren, G. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.19.1669 · Cited by 55
Gattoni‐Celli, S., Kirsch, K., Timpane, R., & Isselbacher, K. J. (1992) · PubMed · Cited by 50
A new β2 microglobulin mutation found in a melanoma tumor cell line
Pérez, B. F., Benitez, R., Fernández, M. A., Oliva, M. R., Soto, J. L., Serrano, S., López‐Nevot, M. Á., & Garrido, F. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.530607.x · Cited by 49
Self-citationHLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines
Koopman, L. A., Mulder, A., Corver, W. E., Anholts, J. D. H., Giphart, M. J., Claas, F. H. J., & Fleuren, G. J. (1998) · Tissue Antigens · doi:10.1111/j.1399-0039.1998.tb03005.x · Cited by 45
Seliger, B., Höhne, A., Jung, D., Kallfelz, M., Knuth, A., Jaeger, E., Bernhard, H., Momburg, F., Tampé, R., & Huber, C. G. (1997) · PubMed · Cited by 40
Self-citationHurks, H. M. H., Metzelaar-Blok, J. A. W., Mulder, A., Claas, F. H. J., & Jager, M. J. (2000) · International Journal of Cancer · Cited by 36
Real, L. M., Jimenez, P., Cantón, J., Kirkin, A. F., Garcia-Lora, A. M., Abril, E., Zeuthen, J., Ruiz‐Cabello, F., & Garrido, F. (1998) · International Journal of Cancer · Cited by 36
Self-citationMéndez, R., Serrano, A., Jäger, E., Maleno, I., Ruiz‐Cabello, F., Knuth, A. K., & Garrido, F. (2001) · Tissue Antigens · doi:10.1034/j.1399-0039.2001.057006508.x · Cited by 35
Self-citationJiménez, P., Cantón, J., Concha, Á., Cabrera, T., Fernández, M., Real, L. M., Garcia-Lora, A. M., Serrano, A., Garrido, F., & Ruiz‐Cabello, F. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050017 · Cited by 20
Self-citation
Cited by
The urgent need to recover MHC class I in cancers for effective immunotherapy
Garrido, F., Aptsiauri, N., Doorduijn, E. M., Garcia Lora, A. M., & van Hall, T. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.12.007 · Cited by 585
Self-citationLiu, Y., Liang, X., Dong, W., Fang, Y., Lv, J., Zhang, T., Fiskesund, R., Xie, J., Liu, J., Yin, X., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.02.005 · Cited by 535
MHC class I antigens, immune surveillance, and tumor immune escape
Garcia‐Lora, A., Algarra, I., & Garrido, F. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10290 · Cited by 501
Self-citationIL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
Mumm, J. B., Emmerich, J., Zhang, X., Chan, I., Wu, L., Mauze, S., Blaisdell, S., Basham, B., Dai, J., Grein, J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.003 · Cited by 418
Danna, E. A., Sinha, P., Gilbert, M., Clements, V. K., Pulaski, B. A., & Ostrand-Rosenberg, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2646 · Cited by 371
Metadata
- Authors
- Seliger, B., Cabrera, T., Garrido, F., & Ferrone, S.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 12
- Issue
- 1
- Pages
- 3-13
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2045246330
- Cited by
- 270
- References
- 45
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.